Burlington Stores Operating Cash Flow decreased by 93.4% to $61.47M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 312.6%, from -$28.91M to $61.47M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 10.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $223.41M | $203.46M | $181.50M | $224.79M | -$172.30M | $19.44M | $162.44M | $586.81M | -$77.95M | $107.78M | $240.37M | $598.54M | $49.37M | $160.43M | $110.41M | $543.16M | -$28.91M | $179.44M | $143.33M | $937.52M | $61.47M |
| QoQ Change | — | -8.9% | -10.8% | +23.9% | -176.6% | +111.3% | +735.7% | +261.2% | -113.3% | +238.3% | +123.0% | +149.0% | -91.8% | +224.9% | -31.2% | +392.0% | -105.3% | +720.7% | -20.1% | +554.1% | -93.4% |
| YoY Change | — | — | — | — | -177.1% | -90.4% | -10.5% | +161.0% | +54.8% | +454.5% | +48.0% | +2.0% | +163.3% | +48.9% | -54.1% | -9.3% | -158.6% | +11.8% | +29.8% | +72.6% | +312.6% |